JENNIFER COOK: Open Payments
NPI 1093316952 · MADISON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,230 in 49 payments from 15 companies in 2025. Trend: 2023 $319 · 2024 $695 · 2025 $1,230
Food & beverage: $1,230
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $271 |
| UCB, Inc. | 7 | $185 |
| Mallinckrodt Hospital Products Inc. | 6 | $142 |
| Janssen Biotech, Inc. | 5 | $111 |
| Galderma Laboratories, L.P. | 5 | $88 |
| Lilly USA, LLC | 3 | $71 |
| GENZYME CORPORATION | 2 | $68 |
| Botanix SB Inc | 3 | $64 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 3 | $47 |
Products named: SKYRIZI, Bimzelx, ACTHAR, TREMFYA, NEMLUVIO, TALTZ, DUPIXENT, SOFDRA.
Industry payments across MS — which companies pay providers there.
